ciprofloxacin has been researched along with Klebsiella Infections in 147 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Klebsiella Infections: Infections with bacteria of the genus KLEBSIELLA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of two fluoroquinolone antimicrobial agents, lomefloxacin and ciprofloxacin, were compared in a randomized, investigator-blinded, multiple-dose study that enrolled 150 adult outpatients with complicated or recurrent urinary tract infections." | 9.07 | A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. ( Cox, CE, 1992) |
| "The aims of this study were to investigate the prevalence of qnrA, qnrB, and qnrS determinants and their molecular characteristics in ciprofloxacin-resistant isolates of Escherichia coli and Klebsiella pneumoniae from urinary tract infections (UTI) in Korea." | 7.74 | High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea. ( Chang, CL; Jung, HJ; Kim, HR; Lee, JN; Lee, JY; Shin, JH, 2008) |
| "This study was performed to examine the ability of ciprofloxacin (CPFX) to suppress the inflammation associated with lipopolysaccharide (LPS) and an inflammatory cytokine in gram-negative bacterial pneumonia." | 7.73 | Effect of ciprofloxacin on levels of lipopolysaccharide and cytokines in experimentally induced gram-negative bacterial pneumonia in mice. ( Kamiya, S; Kawai, S; Kobayashi, O; Nakagawa, T; Sakayori, S, 2006) |
| "This study was designed to compare the killing effect of ciprofloxacin on strains of Klebsiella pneumoniae with different MICs of ciprofloxacin in vivo using the rat granuloma pouch infection model." | 7.71 | Significance of low-level resistance to ciprofloxacin in Klebsiella pneumoniae and the effect of increased dosage of ciprofloxacin in vivo using the rat granuloma pouch model. ( Fuursted, K; Schumacher, H, 2002) |
| "An experimental Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats was used to study the impact of the duration of infection on the bactericidal activity of ceftazidime, gentamicin and ciprofloxacin." | 7.68 | Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. ( Bakker-Woudenberg, IA; Michel, MF; Roosendaal, R; van den Berghe-van Raffe, M; Vink-van den Berg, JC, 1991) |
| "The antibacterial activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in vivo were compared." | 7.67 | Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats. ( Bakker-Woudenberg, IA; Michel, MF; Roosendaal, R; van den Berghe-van Raffe, M; Vink-van den Berg, JC, 1987) |
| "The antibacterial activities of ciprofloxacin versus ceftazidime against Klebsiella pneumoniae in vitro and in vivo were compared." | 7.67 | Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro. ( Bakker-Woudenberg, IA; Michel, MF; Roosendaal, R; van den Berghe-van Raffe, M; Vink-van den Berg, JC, 1987) |
| "The impact of the dosage schedule on the therapeutic efficacy of antibiotics was investigated in experimental Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats." | 5.28 | Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. ( Bakker-Woudenberg, IA; Michel, BM; Roosendaal, R; van den Berghe-van Raffe, M; Vink-van den Berg, JC, 1989) |
| " Adverse reactions were spontaneously reported by four of the 28 patients (14%) and by 11 (39%) after detailed inquiry." | 5.27 | Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections. ( Boerema, J; Boll, B; Branolte, J; Muytjens, H, 1985) |
| "The efficacy and safety of two fluoroquinolone antimicrobial agents, lomefloxacin and ciprofloxacin, were compared in a randomized, investigator-blinded, multiple-dose study that enrolled 150 adult outpatients with complicated or recurrent urinary tract infections." | 5.07 | A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections. ( Cox, CE, 1992) |
| " The vast majority of Enterobacteriaceae, including ESBL producers, remain susceptible to carbapenems, and these agents are considered preferred empiric therapy for serious Enterobacteriaceae infections." | 4.83 | Resistance in gram-negative bacteria: enterobacteriaceae. ( Paterson, DL, 2006) |
| "In vitro activities of colistin and other drugs were tested against 221 Klebsiella pneumoniae isolates that were collected between 2006 and 2007 in nine tertiary care South Korean hospitals from patients with bacteremia." | 3.76 | Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea. ( Chung, DR; Ko, KS; Peck, KR; Son, JS; Song, JH; Suh, JY, 2010) |
| "The aims of this study were to investigate the prevalence of qnrA, qnrB, and qnrS determinants and their molecular characteristics in ciprofloxacin-resistant isolates of Escherichia coli and Klebsiella pneumoniae from urinary tract infections (UTI) in Korea." | 3.74 | High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea. ( Chang, CL; Jung, HJ; Kim, HR; Lee, JN; Lee, JY; Shin, JH, 2008) |
| "This study was performed to examine the ability of ciprofloxacin (CPFX) to suppress the inflammation associated with lipopolysaccharide (LPS) and an inflammatory cytokine in gram-negative bacterial pneumonia." | 3.73 | Effect of ciprofloxacin on levels of lipopolysaccharide and cytokines in experimentally induced gram-negative bacterial pneumonia in mice. ( Kamiya, S; Kawai, S; Kobayashi, O; Nakagawa, T; Sakayori, S, 2006) |
| "This study was designed to compare the killing effect of ciprofloxacin on strains of Klebsiella pneumoniae with different MICs of ciprofloxacin in vivo using the rat granuloma pouch infection model." | 3.71 | Significance of low-level resistance to ciprofloxacin in Klebsiella pneumoniae and the effect of increased dosage of ciprofloxacin in vivo using the rat granuloma pouch model. ( Fuursted, K; Schumacher, H, 2002) |
| " 99mTc-labeled ciprofloxacin does not distinguish between infections and sterile inflammatory lesions, which implies that its specificity for the detection of bacterial infections is not warranted." | 3.71 | 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. ( Balter, HS; Lanzzeri, S; Lupetti, A; Nibbering, PH; Paulusma-Annema, A; Pauwels, EK; Rey, AM; Savio, EO; Souto, B; Welling, MM, 2001) |
| "An experimental Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats was used to study the impact of the duration of infection on the bactericidal activity of ceftazidime, gentamicin and ciprofloxacin." | 3.68 | Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. ( Bakker-Woudenberg, IA; Michel, MF; Roosendaal, R; van den Berghe-van Raffe, M; Vink-van den Berg, JC, 1991) |
| "The antibacterial activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in vivo were compared." | 3.67 | Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats. ( Bakker-Woudenberg, IA; Michel, MF; Roosendaal, R; van den Berghe-van Raffe, M; Vink-van den Berg, JC, 1987) |
| "The antibacterial activities of ciprofloxacin versus ceftazidime against Klebsiella pneumoniae in vitro and in vivo were compared." | 3.67 | Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro. ( Bakker-Woudenberg, IA; Michel, MF; Roosendaal, R; van den Berghe-van Raffe, M; Vink-van den Berg, JC, 1987) |
| "Complex cysts were observed by ultrasonography (in four of eight patients), computed tomography (in six of nine), and magnetic resonance imaging (in two of two)." | 2.38 | Hepatic cyst infection in autosomal dominant polycystic kidney disease. ( Brown, ML; Gross, JB; Hattery, RR; Telenti, A; Torres, VE; Van Scoy, RE, 1990) |
| "The emergence of community acquired infections increases the public health concern on K." | 1.62 | Comparative genomics with a multidrug-resistant Klebsiella pneumoniae isolate reveals the panorama of unexplored diversity in Northeast Brazil. ( Azevedo, V; Barh, D; Brenig, B; Bücker, DH; Caetano, AC; Castro, TLP; Figueiredo, HCP; Gala-Garcia, A; Ghosh, P; Góes-Neto, A; Jaiswal, AK; Kato, RB; Lima-Verde, IB; Meyer, R; Padilha, FF; Profeta, R; Ramos, PIP; Santos, R; Seyffert, N; Soares, SC; Tavares de Oliveira, L; Tiwari, S; Viana, MVC, 2021) |
| "Ciprofloxacin is a quinolone antibiotic used to treat Klebsiella pneumoniae infections in the clinic." | 1.43 | In vitro characterization and inhibition of the interaction between ciprofloxacin and berberine against multidrug-resistant Klebsiella pneumoniae. ( He, LT; He, ZS; Wang, RL; Ye, XG; Zhang, SR; Zhou, J; Zhou, XY, 2016) |
| " Based on patient weight, higher ciprofloxacin dosing regimens should be used in critically ill patients when difficult-to-treat pathogens are suspected." | 1.43 | Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients. ( Lefrant, JY; Lipman, J; Louart, B; Muller, L; Roberts, JA; Roger, C; Wallis, SC, 2016) |
| "The ciprofloxacin treatments (CON-CIP and 1/4CIP-CIP) showed significant reduction in the number of K." | 1.43 | Assessment of antibiotic resistance in Klebsiella pneumoniae exposed to sequential in vitro antibiotic treatments. ( Ahn, J; Chukeatirote, E; Jo, A; Kim, J, 2016) |
| "Bacteriuria was present in 9% of the subjects." | 1.40 | Occurrence of urinary tract infection in adolescent and adult women of shanty town in Dhaka City, Bangladesh. ( Ahmed, MF; Begum, A; Rahman, SR, 2014) |
| "Different complications were recorded: hydrocephalus and brain abscess in one case, respiratory and hemodynamic failure managed in the intensive care unit in the second, and brain hygroma in the third case." | 1.37 | [Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis]. ( Barsaoui, S; Ben Jaballah, N; Bousnina, S; Bouziri, A; Hajji, N; Hariga, D; Kechrid, A; Sammoud, A; Smaoui, H, 2011) |
| "Carbapenems were consistently the most active drugs tested." | 1.36 | Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob ( Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ, 2010) |
| "Ciprofloxacin resistance was significantly linked to ceftazidime resistance, the hallmark of extended-spectrum beta-lactamase production, as well as to resistance to all antibiotic classes tested." | 1.31 | Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe. ( Brisse, S; Fluit, AC; Milatovic, D; Schmitz, FJ; Verhoef, J, 2000) |
| "Ciprofloxacin has been found to be effective in the treatment of multidrug-resistant Gram-negative infections in pediatric patients, including premature infants." | 1.30 | Successful treatment of late-onset infection due to resistant Klebsiella pneumoniae in an extremely low birth weight infant using ciprofloxacin. ( Khaneja, M; Kumar, A; Naprawa, J; Piecuch, S, 1999) |
| "The impact of the dosage schedule on the therapeutic efficacy of antibiotics was investigated in experimental Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats." | 1.28 | Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats. ( Bakker-Woudenberg, IA; Michel, BM; Roosendaal, R; van den Berghe-van Raffe, M; Vink-van den Berg, JC, 1989) |
| " Adverse reactions were spontaneously reported by four of the 28 patients (14%) and by 11 (39%) after detailed inquiry." | 1.27 | Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections. ( Boerema, J; Boll, B; Branolte, J; Muytjens, H, 1985) |
| "Fleroxacin is a newly developed quinolone derivative with marked antimicrobial activity." | 1.27 | Therapeutic effect of fleroxacin against experimental pneumonia in mice. ( Niki, Y; Soejima, R; Tasaka, Y; Umeki, S; Watanabe, M, 1988) |
| "Norfloxacin was ineffective at 200 mg/kg per day against E." | 1.27 | In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones. ( Bower, RR; Chu, DT; Fernandes, PB; Jarvis, KP; Ramer, NR; Shipkowitz, N, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (7.48) | 18.7374 |
| 1990's | 21 (14.29) | 18.2507 |
| 2000's | 47 (31.97) | 29.6817 |
| 2010's | 49 (33.33) | 24.3611 |
| 2020's | 19 (12.93) | 2.80 |
| Authors | Studies |
|---|---|
| Pai, H | 1 |
| Seo, MR | 1 |
| Choi, TY | 1 |
| Strahilevitz, J | 1 |
| Engelstein, D | 1 |
| Adler, A | 1 |
| Temper, V | 1 |
| Moses, AE | 1 |
| Block, C | 1 |
| Robicsek, A | 1 |
| Leavitt, A | 2 |
| Navon-Venezia, S | 2 |
| Chmelnitsky, I | 3 |
| Schwaber, MJ | 1 |
| Carmeli, Y | 3 |
| de Oliveira Garcia, D | 1 |
| Doi, Y | 1 |
| Szabo, D | 2 |
| Adams-Haduch, JM | 1 |
| Vaz, TM | 1 |
| Leite, D | 1 |
| Padoveze, MC | 1 |
| Freire, MP | 1 |
| Silveira, FP | 1 |
| Paterson, DL | 5 |
| Endimiani, A | 2 |
| Carias, LL | 1 |
| Hujer, AM | 2 |
| Bethel, CR | 1 |
| Hujer, KM | 1 |
| Perez, F | 2 |
| Hutton, RA | 1 |
| Fox, WR | 1 |
| Hall, GS | 1 |
| Jacobs, MR | 1 |
| Rice, LB | 1 |
| Jenkins, SG | 1 |
| Tenover, FC | 1 |
| Bonomo, RA | 2 |
| Kiratisin, P | 1 |
| Apisarnthanarak, A | 1 |
| Laesripa, C | 1 |
| Saifon, P | 1 |
| Carrër, A | 1 |
| Poirel, L | 1 |
| Eraksoy, H | 1 |
| Cagatay, AA | 1 |
| Badur, S | 1 |
| Nordmann, P | 2 |
| Gootz, TD | 1 |
| Lescoe, MK | 1 |
| Dib-Hajj, F | 1 |
| Dougherty, BA | 1 |
| He, W | 1 |
| Della-Latta, P | 1 |
| Huard, RC | 1 |
| Baraniak, A | 1 |
| Izdebski, R | 1 |
| Herda, M | 1 |
| Fiett, J | 1 |
| Hryniewicz, W | 1 |
| Gniadkowski, M | 1 |
| Kern-Zdanowicz, I | 1 |
| Filczak, K | 1 |
| Łopaciuk, U | 1 |
| Suh, JY | 1 |
| Son, JS | 1 |
| Chung, DR | 1 |
| Peck, KR | 3 |
| Ko, KS | 2 |
| Song, JH | 2 |
| Yong, D | 1 |
| Toleman, MA | 1 |
| Giske, CG | 1 |
| Cho, HS | 1 |
| Sundman, K | 1 |
| Lee, K | 1 |
| Walsh, TR | 1 |
| Padilla, E | 1 |
| Llobet, E | 1 |
| Doménech-Sánchez, A | 1 |
| Martínez-Martínez, L | 3 |
| Bengoechea, JA | 1 |
| Albertí, S | 1 |
| Rhee, JY | 1 |
| Park, YK | 1 |
| Shin, JY | 1 |
| Choi, JY | 1 |
| Lee, MY | 1 |
| Goren, MG | 1 |
| Ofek, I | 1 |
| Hawser, SP | 1 |
| Bouchillon, SK | 1 |
| Hoban, DJ | 1 |
| Badal, RE | 1 |
| Cantón, R | 2 |
| Baquero, F | 1 |
| Sarciaux, M | 1 |
| Pantel, L | 1 |
| Midrier, C | 1 |
| Serri, M | 1 |
| Gerber, C | 1 |
| Marcia de Figueiredo, R | 1 |
| Campagne, JM | 1 |
| Villain-Guillot, P | 1 |
| Gualtieri, M | 1 |
| Racine, E | 1 |
| Mumtaz, K | 1 |
| Munir, S | 1 |
| Muddassir, M | 1 |
| Raza, A | 1 |
| Waqas, K | 1 |
| Shoaib Ahmed, S | 1 |
| Malik, A | 1 |
| Haider Naqvi, SZ | 1 |
| Mofolorunsho, KC | 1 |
| Ocheni, HO | 1 |
| Aminu, RF | 1 |
| Omatola, CA | 1 |
| Olowonibi, OO | 1 |
| Fujita, K | 1 |
| Takata, I | 1 |
| Yoshida, I | 1 |
| Okumura, H | 1 |
| Otake, K | 1 |
| Takashima, H | 1 |
| Sugiyama, H | 1 |
| Al-Faifi, J | 1 |
| Ibrahim, ME | 1 |
| Oka, K | 1 |
| Tetsuka, N | 1 |
| Morioka, H | 1 |
| Iguchi, M | 1 |
| Kawamura, K | 1 |
| Hayashi, K | 1 |
| Yanagiya, T | 1 |
| Morokuma, Y | 1 |
| Watari, T | 1 |
| Kiyosuke, M | 1 |
| Yagi, T | 1 |
| Jalil, MB | 1 |
| Al Atbee, MYN | 1 |
| Erdem, F | 1 |
| Díez-Aguilar, M | 1 |
| Oksuz, L | 1 |
| Kayacan, C | 1 |
| Abulaila, A | 1 |
| Oncul, O | 1 |
| Morosini, MI | 1 |
| Aktas, Z | 1 |
| Bedenić, B | 1 |
| Pešorda, L | 1 |
| Krilanović, M | 1 |
| Beader, N | 1 |
| Veir, Z | 1 |
| Schoenthaler, S | 1 |
| Bandić-Pavlović, D | 1 |
| Frančula-Zaninović, S | 1 |
| Barišić, I | 1 |
| Tian, C | 1 |
| Xing, M | 1 |
| Zhao, Y | 1 |
| Fan, X | 1 |
| Bai, Y | 1 |
| Fu, L | 1 |
| Wang, S | 1 |
| Albarri, O | 1 |
| AlMatar, M | 1 |
| Var, I | 1 |
| Köksal, F | 1 |
| Cienfuegos-Gallet, AV | 1 |
| Ocampo de Los Ríos, AM | 1 |
| Sierra Viana, P | 1 |
| Ramirez Brinez, F | 1 |
| Restrepo Castro, C | 1 |
| Roncancio Villamil, G | 1 |
| Del Corral Londoño, H | 1 |
| Jiménez, JN | 1 |
| Hossain, S | 1 |
| De Silva, BCJ | 1 |
| Dahanayake, PS | 1 |
| Heo, GJ | 1 |
| Khairy, RMM | 1 |
| Mahmoud, MS | 1 |
| Shady, RR | 1 |
| Esmail, MAM | 1 |
| Abokhalil, RN | 1 |
| Elkhatib, WF | 1 |
| Aboulwafa, MM | 1 |
| Hassouna, NA | 1 |
| Delarampour, A | 1 |
| Ghalehnoo, ZR | 1 |
| Khademi, F | 1 |
| Vaez, H | 1 |
| Yang, X | 1 |
| Hashemi, MM | 1 |
| Andini, N | 1 |
| Li, MM | 1 |
| Kuang, S | 1 |
| Carroll, KC | 1 |
| Wang, TH | 1 |
| Yang, S | 1 |
| Cornée, C | 1 |
| Mainguy, A | 1 |
| Coeuru, D | 1 |
| Routier, M | 1 |
| Lebranchu, P | 1 |
| Vabres, B | 1 |
| Khoshnood, S | 1 |
| Heidary, M | 1 |
| Hashemi, A | 1 |
| Shahi, F | 1 |
| Saki, M | 1 |
| Kouhsari, E | 1 |
| Eslami, G | 1 |
| Goudarzi, H | 1 |
| Profeta, R | 1 |
| Seyffert, N | 1 |
| Tiwari, S | 1 |
| Viana, MVC | 1 |
| Jaiswal, AK | 1 |
| Caetano, AC | 1 |
| Bücker, DH | 1 |
| Tavares de Oliveira, L | 1 |
| Santos, R | 1 |
| Gala-Garcia, A | 1 |
| Kato, RB | 1 |
| Padilha, FF | 1 |
| Lima-Verde, IB | 1 |
| Ghosh, P | 1 |
| Barh, D | 1 |
| Góes-Neto, A | 1 |
| Figueiredo, HCP | 1 |
| Soares, SC | 1 |
| Meyer, R | 1 |
| Brenig, B | 1 |
| Ramos, PIP | 1 |
| Azevedo, V | 1 |
| Castro, TLP | 1 |
| Ren, H | 1 |
| Zhang, J | 1 |
| Zhou, J | 2 |
| Xu, C | 1 |
| Fan, Z | 1 |
| Pan, X | 1 |
| Li, S | 1 |
| Liang, Y | 1 |
| Chen, S | 1 |
| Xu, J | 1 |
| Wang, P | 1 |
| Zhang, Y | 1 |
| Zhu, G | 1 |
| Liu, H | 1 |
| Jin, Y | 1 |
| Bai, F | 1 |
| Cheng, Z | 1 |
| Pletzer, D | 1 |
| Wu, W | 1 |
| Park, SY | 1 |
| Kim, T | 1 |
| Kim, MC | 1 |
| Sung, H | 1 |
| Kim, MN | 1 |
| Kim, SH | 3 |
| Lee, SO | 1 |
| Choi, SH | 1 |
| Woo, JH | 1 |
| Kim, YS | 1 |
| Chong, YP | 1 |
| Qi, DZ | 1 |
| Lehman, K | 1 |
| Dewan, K | 1 |
| Kirimanjeswara, G | 1 |
| Raman, JD | 1 |
| Ko, JH | 1 |
| Lee, NR | 1 |
| Joo, EJ | 1 |
| Moon, SY | 1 |
| Choi, JK | 1 |
| Park, DA | 1 |
| Sayeed, MA | 1 |
| Latif, N | 1 |
| Mahmood, SF | 1 |
| Cojutti, P | 1 |
| Sartor, A | 1 |
| Bassetti, M | 1 |
| Scarparo, C | 1 |
| Pea, F | 1 |
| Younas, S | 1 |
| Ejaz, H | 1 |
| Zafar, A | 1 |
| Ejaz, A | 1 |
| Saleem, R | 1 |
| Javed, H | 1 |
| Agyepong, N | 1 |
| Govinden, U | 1 |
| Owusu-Ofori, A | 1 |
| Amoako, DG | 1 |
| Allam, M | 1 |
| Janice, J | 1 |
| Pedersen, T | 1 |
| Sundsfjord, A | 1 |
| Essack, S | 1 |
| Szili, P | 1 |
| Draskovits, G | 1 |
| Révész, T | 1 |
| Bogár, F | 1 |
| Balogh, D | 1 |
| Martinek, T | 1 |
| Daruka, L | 1 |
| Spohn, R | 1 |
| Vásárhelyi, BM | 1 |
| Czikkely, M | 1 |
| Kintses, B | 1 |
| Grézal, G | 1 |
| Ferenc, G | 1 |
| Pál, C | 1 |
| Nyerges, Á | 1 |
| Rudin, SD | 1 |
| Marshall, SH | 1 |
| Coakley, P | 1 |
| Chen, L | 1 |
| Kreiswirth, BN | 1 |
| Rather, PN | 1 |
| Toltzis, P | 1 |
| van Duin, D | 1 |
| Saiful Anuar, AS | 1 |
| Mohd Yusof, MY | 1 |
| Tay, ST | 1 |
| Molton, J | 1 |
| Phillips, R | 1 |
| Gandhi, M | 1 |
| Yoong, J | 1 |
| Lye, D | 1 |
| Tan, TT | 1 |
| Fisher, D | 1 |
| Archuleta, S | 1 |
| Bert, F | 1 |
| Larroque, B | 1 |
| Dondero, F | 1 |
| Durand, F | 1 |
| Paugam-Burtz, C | 1 |
| Belghiti, J | 1 |
| Moreau, R | 1 |
| Nicolas-Chanoine, MH | 1 |
| Treese, C | 1 |
| Pfaffenbach, S | 1 |
| Daum, S | 1 |
| Rahman, SR | 1 |
| Ahmed, MF | 1 |
| Begum, A | 1 |
| So, W | 1 |
| Crandon, JL | 1 |
| Nicolau, DP | 1 |
| Nakasone, ES | 1 |
| Kaneshiro, R | 1 |
| Min, K | 1 |
| Tokeshi, J | 1 |
| Park, DJ | 1 |
| Yu, JK | 2 |
| Park, KG | 1 |
| Park, YJ | 2 |
| Chen, YT | 1 |
| Siu, LK | 2 |
| Tsai, YK | 1 |
| Lin, FM | 1 |
| Koh, TH | 1 |
| Chen, JH | 1 |
| Zhou, XY | 1 |
| Ye, XG | 1 |
| He, LT | 1 |
| Zhang, SR | 1 |
| Wang, RL | 1 |
| He, ZS | 1 |
| Roger, C | 1 |
| Wallis, SC | 1 |
| Louart, B | 1 |
| Lefrant, JY | 1 |
| Lipman, J | 1 |
| Muller, L | 1 |
| Roberts, JA | 1 |
| Aracil-García, B | 1 |
| Oteo-Iglesias, J | 1 |
| Cuevas-Lobato, Ó | 1 |
| Lara-Fuella, N | 1 |
| Pérez-Grajera, I | 1 |
| Fernández-Romero, S | 1 |
| Pérez-Vázquez, M | 1 |
| Campos, J | 1 |
| Lin, WP | 1 |
| Wang, JT | 1 |
| Chang, SC | 1 |
| Chang, FY | 1 |
| Fung, CP | 1 |
| Chuang, YC | 1 |
| Chen, YS | 1 |
| Shiau, YR | 1 |
| Tan, MC | 1 |
| Wang, HY | 1 |
| Lai, JF | 1 |
| Huang, IW | 1 |
| Lauderdale, TL | 1 |
| Lutz, P | 1 |
| Nischalke, HD | 1 |
| Krämer, B | 1 |
| Goeser, F | 1 |
| Kaczmarek, DJ | 1 |
| Schlabe, S | 1 |
| Parcina, M | 1 |
| Nattermann, J | 1 |
| Hoerauf, A | 1 |
| Strassburg, CP | 1 |
| Spengler, U | 1 |
| Kim, J | 1 |
| Jo, A | 1 |
| Chukeatirote, E | 1 |
| Ahn, J | 1 |
| Ullah, O | 1 |
| Khan, A | 1 |
| Ambreen, A | 1 |
| Ahmad, I | 1 |
| Akhtar, T | 1 |
| Gandapor, AJ | 1 |
| Khan, AM | 1 |
| Rodríguez-Martínez, JM | 2 |
| Pichardo, C | 1 |
| García, I | 2 |
| Pachón-Ibañez, ME | 1 |
| Docobo-Pérez, F | 1 |
| Pascual, A | 3 |
| Pachón, J | 1 |
| Damjanova, I | 1 |
| Tóth, A | 1 |
| Pászti, J | 1 |
| Hajbel-Vékony, G | 1 |
| Jakab, M | 1 |
| Berta, J | 1 |
| Milch, H | 1 |
| Füzi, M | 1 |
| Shin, JH | 1 |
| Jung, HJ | 1 |
| Lee, JY | 1 |
| Kim, HR | 1 |
| Lee, JN | 1 |
| Chang, CL | 1 |
| Pinsky, BA | 1 |
| Baron, EJ | 1 |
| Janda, JM | 1 |
| Banaei, N | 1 |
| Drago, L | 1 |
| Nicola, L | 1 |
| Mattina, R | 1 |
| De Vecchi, E | 1 |
| Aathithan, S | 2 |
| French, GL | 2 |
| Piekarska, K | 1 |
| Zacharczuk, K | 1 |
| Szych, J | 1 |
| Zawidzka, E | 1 |
| Wilk, E | 1 |
| Wardak, S | 1 |
| Jagielski, M | 1 |
| Gierczyński, R | 1 |
| Kim, SY | 1 |
| Lee, S | 1 |
| Jeong, SH | 1 |
| Aygencel, G | 1 |
| Dizbay, M | 1 |
| Smaoui, H | 1 |
| Hariga, D | 1 |
| Hajji, N | 1 |
| Bouziri, A | 1 |
| Ben Jaballah, N | 1 |
| Barsaoui, S | 1 |
| Bousnina, S | 1 |
| Sammoud, A | 1 |
| Kechrid, A | 1 |
| Lester, CH | 1 |
| Olsen, SS | 1 |
| Jakobsen, L | 1 |
| Arpi, M | 1 |
| Fuursted, K | 2 |
| Hansen, DS | 1 |
| Heltberg, O | 1 |
| Holm, A | 1 |
| Højbjerg, T | 1 |
| Jensen, KT | 1 |
| Johansen, HK | 1 |
| Justesen, US | 1 |
| Kemp, M | 1 |
| Knudsen, JD | 1 |
| Røder, B | 1 |
| Frimodt-Møller, N | 1 |
| Hammerum, AM | 1 |
| Noguera, O | 1 |
| López-Riquelme, N | 1 |
| Rodríguez, JC | 1 |
| Belda, S | 1 |
| Galiana, A | 1 |
| Ruiz-García, M | 1 |
| López-García, P | 1 |
| Royo, G | 1 |
| Lin, CJ | 1 |
| Ma, L | 1 |
| Chang, YT | 1 |
| Lu, PL | 1 |
| Batres Iglesias, AP | 1 |
| Pérez Cabeza, MI | 1 |
| Del Río Pardo, MJ | 1 |
| Castaño, M | 1 |
| Haenni, M | 1 |
| Ponsin, C | 1 |
| Métayer, V | 1 |
| Médaille, C | 1 |
| Madec, JY | 1 |
| Halaby, T | 1 |
| Reuland, AE | 1 |
| Al Naiemi, N | 1 |
| Potron, A | 1 |
| Savelkoul, PH | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Elgorriaga-Islas, E | 1 |
| Guggiana-Nilo, P | 1 |
| Domínguez-Yévenes, M | 1 |
| González-Rocha, G | 1 |
| Mella-Montecinos, S | 1 |
| Labarca-Labarca, J | 1 |
| García-Cañete, P | 1 |
| Bello-Toledo, H | 1 |
| Marra, A | 1 |
| Lamb, L | 1 |
| Medina, I | 1 |
| George, D | 1 |
| Gibson, G | 1 |
| Hardink, J | 1 |
| Rugg, J | 1 |
| Van Deusen, J | 1 |
| O'Donnell, JP | 1 |
| Schmiemann, G | 1 |
| Gágyor, I | 1 |
| Hummers-Pradier, E | 1 |
| Bleidorn, J | 1 |
| Afolabi, OA | 1 |
| Salaudeen, AG | 1 |
| Ologe, FE | 1 |
| Nwabuisi, C | 1 |
| Nwawolo, CC | 1 |
| Schumacher, H | 1 |
| Yu, WL | 1 |
| Jones, RN | 1 |
| Hollis, RJ | 1 |
| Messer, SA | 1 |
| Biedenbach, DJ | 1 |
| Deshpande, LM | 1 |
| Pfaller, MA | 1 |
| Bermejo, J | 2 |
| Lesnaberes, P | 2 |
| Arnesi, N | 2 |
| Gianello, M | 1 |
| Notario, R | 2 |
| Borda, N | 2 |
| Gambandé, T | 1 |
| Bencomo, B | 2 |
| Fendukly, F | 1 |
| Karlsson, I | 1 |
| Hanson, HS | 1 |
| Kronvall, G | 1 |
| Dornbusch, K | 1 |
| Bagia, JS | 1 |
| Hall, R | 1 |
| Luzzaro, F | 1 |
| Perilli, M | 1 |
| Lombardi, G | 1 |
| Colì, A | 1 |
| Tamborini, A | 1 |
| Amicosante, G | 1 |
| Toniolo, A | 1 |
| Tolun, V | 1 |
| Küçükbasmaci, O | 1 |
| Törümküney-Akbulut, D | 1 |
| Catal, C | 1 |
| Anğ-Küçüker, M | 1 |
| Anğ, O | 1 |
| Kang, CI | 2 |
| Kim, DM | 1 |
| Park, WB | 1 |
| Lee, KD | 1 |
| Kim, HB | 2 |
| Oh, MD | 2 |
| Kim, EC | 2 |
| Choe, KW | 2 |
| Chen, J | 1 |
| Cachay, ER | 1 |
| Hunt, GC | 1 |
| Nijssen, S | 1 |
| Florijn, A | 1 |
| Bonten, MJ | 1 |
| Schmitz, FJ | 2 |
| Verhoef, J | 2 |
| Fluit, AC | 2 |
| Kizirgil, A | 1 |
| Demirdag, K | 1 |
| Ozden, M | 1 |
| Bulut, Y | 1 |
| Yakupogullari, Y | 1 |
| Toraman, ZA | 1 |
| Chidzonga, MM | 1 |
| Fragoulis, KN | 1 |
| Klouvas, GD | 1 |
| Falagas, ME | 1 |
| Wyss Lustenberger, R | 1 |
| Dashti, AA | 1 |
| Paton, R | 1 |
| Amyes, SG | 1 |
| Adams, BK | 1 |
| Youssef, I | 1 |
| Parkar, S | 1 |
| Velasco, C | 1 |
| Kawai, S | 1 |
| Nakagawa, T | 1 |
| Sakayori, S | 1 |
| Kobayashi, O | 1 |
| Kamiya, S | 1 |
| Zimhony, O | 1 |
| Bardenstein, R | 1 |
| Goland, S | 1 |
| Hammer Muntz, O | 1 |
| Navon Venezia, S | 1 |
| Bang, JW | 1 |
| Kim, NJ | 1 |
| de Cueto, M | 1 |
| Hernández, JR | 1 |
| López-Cerero, L | 1 |
| Morillo, C | 1 |
| Vandijck, DM | 1 |
| Decruyenaere, JM | 1 |
| Depuydt, PO | 1 |
| Blot, SI | 1 |
| Chau, NG | 1 |
| Bhatia, S | 1 |
| Raman, M | 1 |
| Wang, A | 1 |
| Yang, Y | 1 |
| Lu, Q | 1 |
| Wang, Y | 1 |
| Chen, Y | 1 |
| Deng, L | 1 |
| Ding, H | 1 |
| Deng, Q | 1 |
| Wang, L | 1 |
| Shen, X | 1 |
| Klesel, N | 2 |
| Geweniger, KH | 1 |
| Koletzki, P | 1 |
| Isert, D | 1 |
| Limbert, M | 2 |
| Markus, A | 1 |
| Riess, G | 1 |
| Schramm, H | 1 |
| Iyer, P | 1 |
| Yu, L | 1 |
| Chen, YL | 1 |
| Zhu, YJ | 1 |
| Grando, V | 1 |
| Bellaïche, G | 1 |
| Le Pennec, MP | 1 |
| Slama, JL | 1 |
| Ley, G | 1 |
| Nouts, A | 1 |
| Paugam, B | 1 |
| Belliveau, PP | 1 |
| Nightingale, CH | 1 |
| Qunitiliani, R | 1 |
| Maderazo, EG | 1 |
| Sarkar, S | 1 |
| Singh, M | 1 |
| Narang, A | 1 |
| Chayakul, P | 1 |
| Krisanapan, S | 1 |
| Kalnauwakul, S | 1 |
| Hobson, RP | 1 |
| MacKenzie, FM | 1 |
| Gould, IM | 1 |
| Deguchi, T | 1 |
| Fukuoka, A | 1 |
| Yasuda, M | 1 |
| Nakano, M | 1 |
| Ozeki, S | 1 |
| Kanematsu, E | 1 |
| Nishino, Y | 1 |
| Ishihara, S | 1 |
| Ban, Y | 1 |
| Kawada, Y | 1 |
| Leblanc, M | 1 |
| Pillay, T | 1 |
| Pillay, DG | 1 |
| Adhikari, M | 1 |
| Sturm, AW | 1 |
| Gupta, D | 1 |
| Sinha, R | 1 |
| Hostacká, A | 2 |
| Karelová, E | 1 |
| Gilad, J | 1 |
| Borer, A | 1 |
| Maimon, N | 1 |
| Riesenberg, K | 1 |
| Klein, M | 1 |
| Schlaeffer, F | 1 |
| Thadepalli, H | 1 |
| Reddy, U | 1 |
| Chuah, SK | 1 |
| Hanna, N | 1 |
| Rana, G | 1 |
| Gollapudi, S | 1 |
| Khaneja, M | 1 |
| Naprawa, J | 1 |
| Kumar, A | 1 |
| Piecuch, S | 1 |
| Brisse, S | 1 |
| Milatovic, D | 1 |
| Mulazimoglu, L | 1 |
| Casellas, JM | 1 |
| Ko, WC | 1 |
| Goossens, H | 1 |
| Von Gottberg, A | 1 |
| Mohapatra, S | 1 |
| Trenholme, GM | 1 |
| Klugman, KP | 1 |
| McCormack, JG | 1 |
| Yu, VL | 1 |
| Bakker-Woudenberg, IA | 5 |
| ten Kate, MT | 1 |
| Guo, L | 1 |
| Working, P | 1 |
| Mouton, JW | 1 |
| Welling, MM | 1 |
| Lupetti, A | 1 |
| Balter, HS | 1 |
| Lanzzeri, S | 1 |
| Souto, B | 1 |
| Rey, AM | 1 |
| Savio, EO | 1 |
| Paulusma-Annema, A | 1 |
| Pauwels, EK | 1 |
| Nibbering, PH | 1 |
| Salas Coronas, J | 1 |
| Gallego Rojo, FJ | 1 |
| Sánchez Sánchez, JC | 1 |
| Díez García, F | 1 |
| Máthé, A | 1 |
| Lengyel, J | 1 |
| Anderlik, P | 1 |
| Rókusz, L | 1 |
| Rozgonyi, F | 1 |
| Cox, CE | 1 |
| Garcia Rodriguez, JA | 1 |
| Montes Martinez, I | 1 |
| Gómez González, JL | 1 |
| Ramos Macías, A | 1 |
| López Alburquerque, T | 1 |
| Roosendaal, R | 4 |
| van den Berghe-van Raffe, M | 4 |
| Vink-van den Berg, JC | 4 |
| Michel, MF | 3 |
| Lumbiganon, P | 1 |
| Pengsaa, K | 1 |
| Sookpranee, T | 1 |
| Brook, I | 1 |
| Elliott, TB | 1 |
| Ledney, GD | 1 |
| Telenti, A | 1 |
| Torres, VE | 1 |
| Gross, JB | 1 |
| Van Scoy, RE | 1 |
| Brown, ML | 1 |
| Hattery, RR | 1 |
| Michel, BM | 1 |
| Ying, LS | 1 |
| Johnson, CA | 1 |
| Houwen, RH | 1 |
| Bijleveld, CM | 1 |
| de Vries-Hospers, HG | 1 |
| Boerema, J | 1 |
| Boll, B | 1 |
| Muytjens, H | 1 |
| Branolte, J | 1 |
| Seibert, G | 1 |
| Winkler, I | 1 |
| Schrinner, E | 1 |
| Gargallo, D | 1 |
| Moros, M | 1 |
| Coll, R | 1 |
| Esteve, M | 1 |
| Parés, J | 1 |
| Xicota, MA | 1 |
| Guinea, J | 1 |
| Niki, Y | 1 |
| Watanabe, M | 1 |
| Tasaka, Y | 1 |
| Umeki, S | 1 |
| Soejima, R | 1 |
| Trautmann, M | 1 |
| Brückner, O | 1 |
| Marre, R | 1 |
| Hahn, H | 1 |
| Fernandes, PB | 1 |
| Chu, DT | 1 |
| Bower, RR | 1 |
| Jarvis, KP | 1 |
| Ramer, NR | 1 |
| Shipkowitz, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety and Efficacy Study of Eradication of Carbapenem Resistant Klebsiella Pneumonia From the Gastrointestinal Tract by Probiotics.[NCT00722410] | Phase 1/Phase 2 | 60 participants (Anticipated) | Interventional | 2008-09-30 | Not yet recruiting | ||
| A Multi-centre Randomised Open-label Active Comparator-controlled Non-inferiority Trial Comparing Oral to Intravenous Antibiotics in the Early Management of Klebsiella Pneumoniae Liver Abscess[NCT01723150] | Phase 4 | 152 participants (Actual) | Interventional | 2013-11-05 | Completed | ||
| A Multicentre, Open-label, Single-arm Phase II Trial on the Efficacy and Safety of Sclerotherapy Using 3% Polidocanol Foam to Treat Second-degree Hemorrhoidal Disease[NCT03791775] | Phase 2 | 183 participants (Actual) | Interventional | 2019-01-02 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for ciprofloxacin and Klebsiella Infections
| Article | Year |
|---|---|
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community- | 2006 |
Management of placenta accreta with oral methotrexate.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Disease-Free Survival; Endosonogr | 1998 |
Hepatic cyst infection in autosomal dominant polycystic kidney disease.
Topics: Aged; Ciprofloxacin; Cysts; Enterobacter; Enterobacteriaceae Infections; Escherichia coli Infections | 1990 |
3 trials available for ciprofloxacin and Klebsiella Infections
| Article | Year |
|---|---|
Oral versus intravenous antibiotics for patients with Klebsiella pneumoniae liver abscess: study protocol for a randomized controlled trial.
Topics: Administration, Intravenous; Administration, Oral; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin | 2013 |
Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin.
Topics: Bacteremia; beta-Lactamases; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Imipenem; Kl | 2004 |
A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Escherichia coli Infections; F | 1992 |
141 other studies available for ciprofloxacin and Klebsiella Infections
| Article | Year |
|---|---|
Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; | 2007 |
Changes in qnr prevalence and fluoroquinolone resistance in clinical isolates of Klebsiella pneumoniae and Enterobacter spp. collected from 1990 to 2005.
Topics: Anti-Infective Agents; Bacteremia; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; En | 2007 |
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Hos | 2007 |
Multiclonal outbreak of Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-2 and novel variant CTX-M-59 in a neonatal intensive care unit in Brazil.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Brazil; Cephalosporins; Disease Outbreak | 2008 |
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistan | 2008 |
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
Topics: Adult; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; El | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Elect | 2008 |
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; | 2009 |
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Inf | 2009 |
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
Topics: Anti-Bacterial Agents; Bacteremia; Colistin; Cross Infection; Drug Resistance, Bacterial; Humans; Kl | 2010 |
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime | 2009 |
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Culture Media; Defensins; DNA, Bacteri | 2010 |
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infection | 2010 |
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Israel; Klebsi | 2010 |
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Esc | 2010 |
Total Synthesis and Structure-Activity Relationships Study of Odilorhabdins, a New Class of Peptides Showing Potent Antibacterial Activity.
Topics: Animals; Anti-Bacterial Agents; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbia | 2018 |
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug | 2021 |
Prevalence and antimicrobial susceptibility of extended-spectrum beta lactamases-producing
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cipro | 2021 |
TP0586532, a non-hydroxamate LpxC inhibitor, has in vitro and in vivo antibacterial activities against Enterobacteriaceae.
Topics: Amidohydrolases; Animals; Anti-Bacterial Agents; Chelating Agents; Ciprofloxacin; Drug Resistance, M | 2022 |
Congenital brucellosis associated with subsequent Klebsiella pneumoniae co-infection in a premature neonate: A rare case report.
Topics: Amikacin; Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Coinfection; Female; Gentamicins; Human | 2022 |
Genetic and epidemiological analysis of ESBL-producing Klebsiella pneumoniae in three Japanese university hospitals.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Enterobacteriaceae; Hospitals, University; Hu | 2022 |
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Dru | 2022 |
Time kill-assays of antibiotic combinations for multidrug resistant clinical isolates of OXA-48 carbapenemase producing Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Colistin; Drug Synergism; | 2022 |
Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxac | 2022 |
Whole genome sequencing of OXA-232-producing
Topics: Amikacin; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Chromosomes; Ciprof | 2022 |
Antimicrobial Resistance of Clinical
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Kle | 2024 |
Risk factors and survival of patients infected with carbapenem-resistant Klebsiella pneumoniae in a KPC endemic setting: a case-control and cohort study.
Topics: Aged; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Case-Control Studies; Cefepime | 2019 |
Phylogenetic relationships, virulence and antimicrobial resistance properties of Klebsiella sp. isolated from pet turtles in Korea.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Bacterial; Humans; | 2020 |
Multidrug-resistant Klebsiella pneumoniae in hospital-acquired infections: Concomitant analysis of antimicrobial resistant strains.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Child; Ciprofloxacin; | 2020 |
Persisters of Klebsiella pneumoniae and Proteus mirabilis: A Common Phenomenon and Different Behavior Profiles.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Kle | 2020 |
Antibiotic resistance patterns and prevalence of class I, II and III Integrons among clinical isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Cefepime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; F | 2020 |
RNA markers for ultra-rapid molecular antimicrobial susceptibility testing in fluoroquinolone-treated Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fluoroquinolones; Humans; Klebsiella Infections; Klebsiella pn | 2020 |
[Corneal ulcer secondary to Pasteurella multocida and Klebsiella oxytoca in a 79-year-old patient with dysthyroid orbitopathy].
Topics: Aged; Amnion; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Coinfection; Combined Modality Ther | 2020 |
Involvement of the AcrAB Efflux Pump in Ciprofloxacin Resistance in Clinical Klebsiella Pneumoniae Isolates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Iran; Klebsiella Infection | 2021 |
Comparative genomics with a multidrug-resistant Klebsiella pneumoniae isolate reveals the panorama of unexplored diversity in Northeast Brazil.
Topics: Adult; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Female; G | 2021 |
Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Biofilms; Ciprofloxacin; Codon; Dogs; Drug Resistance, | 2021 |
Ciprofloxacin treatment for cryptogenic Klebsiella pneumoniae liver abscesses.
Topics: Ciprofloxacin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess | 2017 |
Preoperative urine culture is unnecessary in asymptomatic men prior to prostate needle biopsy.
Topics: Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Asymptomatic Diseases; Bacteriuria; Biopsy, Nee | 2018 |
Appropriate non-carbapenems are not inferior to carbapenems as initial empirical therapy for bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a propensity score weighted multicenter cohort study.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Ciprofloxacin; Esc | 2018 |
Hypermucoviscous Klebsiella syndrome it's in the community!
Topics: Anti-Bacterial Agents; Ciprofloxacin; Humans; Klebsiella; Klebsiella Infections; Male; Middle Aged; | 2017 |
Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?
Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Ciprofloxacin; Drug Resistance, Bact | 2018 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefo | 2018 |
Genomic characterization of multidrug-resistant ESBL-producing Klebsiella pneumoniae isolated from a Ghanaian teaching hospital.
Topics: Aminoglycosides; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, B | 2019 |
Rapid Evolution of Reduced Susceptibility against a Balanced Dual-Targeting Antibiotic through Stepping-Stone Mutations.
Topics: Acenaphthenes; Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Directed Molecular | 2019 |
OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin.
Topics: Americas; Animals; Anti-Bacterial Agents; Asia; Australia; Ciprofloxacin; Drug Resistance, Multiple, | 2013 |
Prevalence of plasmid-mediated qnr determinants and gyrase alteration in Klebsiella pneumoniae isolated from a university teaching hospital in Malaysia.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Cross Infection; DNA Gyrase; Drug Resistan | 2013 |
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial | 2014 |
Uncommon case of ulcerative esophagitis.
Topics: Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Enterobacter cloacae; Enterobacteriaceae Infections; E | 2014 |
Occurrence of urinary tract infection in adolescent and adult women of shanty town in Dhaka City, Bangladesh.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteriuria; Bangladesh; Ciproflo | 2014 |
Effects of Urine Matrix and pH on the Potency of Delafloxacin and Ciprofloxacin against Urogenic Escherichia coli and Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ciprofloxacin; Escherichia coli; | 2015 |
Emergence of Raoultella ornithinolytica on O'ahu: a case of community-acquired R. ornithinolytica urinary tract infection.
Topics: Ciprofloxacin; Community-Acquired Infections; Female; Humans; Klebsiella Infections; Urinary Tract I | 2015 |
Genotypes of Ciprofloxacin-Resistant Klebsiella pneumoniae in Korea and Their Characteristics According to the Genetic Lineages.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; Ciprofloxacin; Clone Cell | 2015 |
A Common Flanking Region in Promiscuous Plasmids Encoding blaNDM-1 in Klebsiella pneumoniae Isolated in Singapore.
Topics: Anti-Bacterial Agents; Aztreonam; Base Sequence; beta-Lactamases; Ciprofloxacin; Conjugation, Geneti | 2016 |
In vitro characterization and inhibition of the interaction between ciprofloxacin and berberine against multidrug-resistant Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Berberine; Ciprofloxacin; Drug Resistance, Multiple, Bact | 2016 |
Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Ciprofloxacin; Criti | 2016 |
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bact | 2017 |
The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Ge | 2016 |
Antibiotic resistance in healthcare-related and nosocomial spontaneous bacterial peritonitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Cross Infection; Drug | 2017 |
Assessment of antibiotic resistance in Klebsiella pneumoniae exposed to sequential in vitro antibiotic treatments.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Drug Resistance, Bacteria | 2016 |
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacteri | 2016 |
Activity of ciprofloxacin and levofloxacin in experimental pneumonia caused by Klebsiella pneumoniae deficient in porins, expressing active efflux and producing QnrA1.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Colony Count, Microbial; Drug Res | 2008 |
Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Ciprofloxa | 2008 |
High rates of plasmid-mediated quinolone resistance QnrB variants among ciprofloxacin-resistant Escherichia coli and Klebsiella pneumoniae from urinary tract infections in Korea.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia co | 2008 |
Bartholin's abscess caused by hypermucoviscous Klebsiella pneumoniae.
Topics: Abscess; Adult; Anti-Bacterial Agents; Bartholin's Glands; Ciprofloxacin; Drainage; Female; Humans; | 2009 |
In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Ciprofloxacin; Dioxolanes; DNA Gyrase; DNA Mutational Ana | 2010 |
Hypermutability in clinical isolates of Klebsiella pneumoniae is uncommon and is unrelated to ciprofloxacin resistance.
Topics: Anti-Bacterial Agents; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; | 2010 |
[Dissemination of the KPC carbapenemase producing Klebsiella pneumoniae in a hospital in Warsaw, Poland].
Topics: Adult; Aged; Aztreonam; Bacterial Proteins; beta-Lactamases; Cefotaxime; Ceftazidime; Ciprofloxacin; | 2010 |
Prevalence and characteristics of qnr determinants and aac(6')-Ib-cr among ciprofloxacin-susceptible isolates of Klebsiella pneumoniae in Korea.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ciprofloxacin; Human | 2010 |
Severe systemic sepsis due to pyogenic liver abscess.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Klebsi | 2012 |
[Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis].
Topics: beta-Lactam Resistance; Brain Abscess; Brain Damage, Chronic; Ciprofloxacin; Drug Therapy, Combinati | 2011 |
Prevalence and role of efflux pump activity in ciprofloxacin resistance in clinical isolates of Klebsiella pneumoniae.
Topics: Anti-Bacterial Agents; Biological Transport, Active; Carbon Radioisotopes; Carbonyl Cyanide m-Chloro | 2011 |
Emergence of extended-spectrum β-lactamase (ESBL)-producing Klebsiella pneumoniae in Danish hospitals; this is in part explained by spread of two CTX-M-15 clones with multilocus sequence types 15 and 16 in Zealand.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Denmark; Genotype; Gentamicins; Hospitals; Hu | 2011 |
Fluoroquinolone resistance in Escherichia coli and Klebsiella pneumoniae over 18 years: effect of different systems for eliminating duplicates.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Escherichia coli | 2011 |
Molecular epidemiology of ciprofloxacin-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Taiwan.
Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Child; Ciprofloxacin; Conjugation | 2012 |
[Endogenous endophthalmitis as a first clinical manifestation of Klebsiella sepsis. The importance of an early diagnosis].
Topics: Anti-Bacterial Agents; Bacteremia; Chorioretinitis; Choroid Hemorrhage; Ciprofloxacin; Combined Moda | 2011 |
Veterinary hospital-acquired infections in pets with a ciprofloxacin-resistant CTX-M-15-producing Klebsiella pneumoniae ST15 clone.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cat Diseases; Cats; Ciprofloxacin; Cross Infection; | 2012 |
A case of New Delhi metallo-β-lactamase 1 (NDM-1)-producing Klebsiella pneumoniae with putative secondary transmission from the Balkan region in the Netherlands.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Coinfection; Fe | 2012 |
[Prevalence of plasmid-mediated quinolone resistance determinant aac(6')-Ib-cr among ESBL producing enterobacteria isolates from Chilean hospitals].
Topics: Acetylation; Anti-Bacterial Agents; Bacterial Proteins; Chile; Ciprofloxacin; Cross Infection; Drug | 2012 |
Effect of linezolid on the 50% lethal dose and 50% protective dose in treatment of infections by Gram-negative pathogens in naive and immunosuppressed mice and on the efficacy of ciprofloxacin in an acute murine model of septicemia.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Ciprofloxacin; Drug Administration Routes; Drug Administ | 2012 |
Resistance profiles of urinary tract infections in general practice--an observational study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, B | 2012 |
Pattern of bacterial isolates in the middle ear discharge of patients with chronic suppurative otitis media in a tertiary hospital in North central Nigeria.
Topics: Adolescent; Adult; Age Distribution; Anti-Bacterial Agents; Child; Child, Preschool; Chronic Disease | 2012 |
Significance of low-level resistance to ciprofloxacin in Klebsiella pneumoniae and the effect of increased dosage of ciprofloxacin in vivo using the rat granuloma pouch model.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Resistance, Bacterial; G | 2002 |
Molecular epidemiology of extended-spectrum beta-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan.
Topics: Anti-Infective Agents; beta-Lactam Resistance; beta-Lactamases; Ciprofloxacin; Drug Resistance, Mult | 2002 |
[Risk factors associated with ceftazidime-resistant Klebsiella pneumoniae infection].
Topics: Aged; Aged, 80 and over; Argentina; Bacterial Proteins; beta-Lactamases; Case-Control Studies; Cefta | 2003 |
Patterns of mutations in target genes in septicemia isolates of Escherichia coli and Klebsiella pneumoniae with resistance or reduced susceptibility to ciprofloxacin.
Topics: Anti-Infective Agents; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; | 2003 |
Extracranial mycotic carotid pseudoaneurysm.
Topics: Aneurysm, False; Aneurysm, Infected; Anti-Infective Agents; Carotid Artery Diseases; Carotid Artery, | 2003 |
Relationship between ciprofloxacin resistance and extended-spectrum beta-lactamase production in Escherichia coli and Klebsiella pneumoniae strains.
Topics: Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; | 2004 |
Risk Factors for Ciprofloxacin Resistance in Bloodstream Infections Due to Extended-Spectrum beta-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacteremia; beta-Lactamases; Case-Control Studies; Cipro | 2004 |
Klebsiella oxytoca: a rare cause of severe infectious colitis: first North American case report.
Topics: Aged; Anti-Infective Agents; Ciprofloxacin; Colitis; Colon, Sigmoid; Humans; Klebsiella Infections; | 2004 |
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalo | 2004 |
In vitro activity of three different antimicrobial agents against ESBL producing Escherichia coli and Klebsiella pneumoniae blood isolates.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Blood; Ciprofloxacin; Drug Resistance, | 2005 |
Necrotizing fasciitis of the cervical region in an AIDS patient: report of a case.
Topics: AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Dental Car | 2005 |
Impetigo-like vegetating nasal lesions caused by Klebsiella pneumoniae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ciprofloxacin; Facial Dermatos | 2005 |
[A young athletic man with dysuria and shivering].
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Ciprofloxacin; Diagnosis, Differential; Follow-Up Studi | 2005 |
Linkage of ciprofloxacin resistance with a single genotypic cluster of Klebsiella pneumoniae.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; Ciprofloxacin; DNA | 2006 |
Absent Tc-99m ciprofloxacin (infecton) uptake in a renal abscess.
Topics: Abscess; Adult; Ciprofloxacin; Humans; Kidney Diseases; Klebsiella Infections; Male; Organotechnetiu | 2006 |
Correlation of quinolone resistance levels and differences in basal and quinolone-induced expression from three qnrA-containing plasmids.
Topics: Anti-Infective Agents; Aza Compounds; Bacterial Proteins; Blotting, Northern; Blotting, Southern; Ci | 2006 |
Effect of ciprofloxacin on levels of lipopolysaccharide and cytokines in experimentally induced gram-negative bacterial pneumonia in mice.
Topics: Animals; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Ciprofloxacin; Cytokines; Klebsiella I | 2006 |
Endocarditis caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae: emergence of resistance to ciprofloxacin and piperacillin-tazobactam during treatment despite initial susceptibility.
Topics: beta-Lactamases; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Endocarditis, Bacterial; Femal | 2006 |
Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Cephalosporins; Ciprofloxacin; Commu | 2006 |
[High relationship between ciprofloxacin use and prevalence of ESBL Klebsiella pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Ciprofloxacin; Cross-Sectional Studies; Drug | 2006 |
[Activity of fosfomycin against extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; beta-L | 2006 |
Community-acquired versus nosocomial Klebsiella pneumonia bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cro | 2007 |
Pylephlebitis and pyogenic liver abscesses: a complication of hemorrhoidal banding.
Topics: Anti-Infective Agents; Ciprofloxacin; Diabetes Mellitus, Type 2; Hemorrhoids; Humans; Immunocompromi | 2007 |
Occurrence of qnr-positive clinical isolates in Klebsiella pneumoniae producing ESBL or AmpC-type beta-lactamase from five pediatric hospitals in China.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Child; Child, Preschool; China; Ciprofl | 2008 |
Chemotherapeutic activity of levofloxacin (HR 355, DR-3355) against systemic and localized infections in laboratory animals.
Topics: Abscess; Animals; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Female; Granuloma; Kle | 1995 |
[Clinical analysis of 60 cases of nosocomal pneumonias].
Topics: Adult; Ciprofloxacin; Cross Infection; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pneumon | 1994 |
[Ulcerative hemorrhagic proctitis caused by Klebsiella oxytoca after treatment with an amoxicillin-clavulanic acid combination].
Topics: Adult; Amoxicillin; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Colitis, Ulcerative; Drug Resi | 1994 |
Reduction in serum concentrations of ciprofloxacin after administration of ursodiol to a patient with hepatobiliary disease.
Topics: Bacteremia; Biliary Tract Diseases; Ciprofloxacin; Drug Interactions; Humans; Klebsiella Infections; | 1994 |
Successful treatment of hospital acquired Klebsiella pneumoniae meningitis in a neonate with ciprofloxacin.
Topics: Ciprofloxacin; Cross Infection; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumonia | 1993 |
Sequential intravenous/oral ciprofloxacin in the treatment of severe multiresistant gram-negative infections.
Topics: Administration, Oral; Adolescent; Adult; Ciprofloxacin; Drug Resistance, Microbial; Female; Gram-Neg | 1993 |
An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cefotaxime; Ceftazidime; Cefuroxime; Cephal | 1996 |
Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.
Topics: Amino Acid Sequence; Anti-Infective Agents; Base Sequence; Cephalosporins; Ciprofloxacin; DNA Gyrase | 1997 |
Oral ciprofloxacin to treat bacterial peritonitis associated with peritoneal dialysis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Ciprofloxacin; Escherichia coli; Escherichia coli | 1997 |
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cilastatin; Ciprofloxacin; Cross Infection; Drug C | 1998 |
Hydrophobicity and serum sensitivity of Klebsiella pneumoniae treated with sub-MICs of quinolones.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Cell Membrane; Ciprofloxacin; Enoxacin; Humans; | 1997 |
Outer membrane proteins of Klebsiella pneumoniae after exposure to ciprofloxacin.
Topics: Anti-Infective Agents; Bacterial Outer Membrane Proteins; Ciprofloxacin; Electrophoresis, Polyacryla | 1998 |
Failure of ciprofloxacin prophylaxis for ultrasound guided transrectal prostatic biopsy in the era of multiresistant enterobacteriaceae.
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Biopsy; Ciprofloxacin; Drug Resistance, Microbi | 1999 |
Evaluation of trovafloxacin in the treatment of Klebsiella pneumoniae lung infection in tumour-bearing mice.
Topics: Animals; Anti-Infective Agents; Antibiotics, Antineoplastic; Ciprofloxacin; Daunorubicin; Drug Evalu | 2000 |
Successful treatment of late-onset infection due to resistant Klebsiella pneumoniae in an extremely low birth weight infant using ciprofloxacin.
Topics: Age of Onset; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combina | 1999 |
Epidemiology of quinolone resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Typing Techniques; Ciprofloxacin; Drug Resis | 2000 |
Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia.
Topics: Anti-Infective Agents; Bacteremia; beta-Lactamases; Ciprofloxacin; Cross Infection; Drug Resistance, | 2000 |
Improved efficacy of ciprofloxacin administered in polyethylene glycol-coated liposomes for treatment of Klebsiella pneumoniae pneumonia in rats.
Topics: Animals; Anti-Infective Agents; Ciprofloxacin; Disease Models, Animal; Drug Carriers; Drug Delivery | 2001 |
99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Infections; Candidiasis; | 2001 |
[Medical treatment of infected pancreatic necrosis].
Topics: Aged; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Gentamicins; Humans; Imip | 2001 |
In vitro and in vivo activities of ciprofloxacin and levofloxacin against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
Topics: Animals; Anti-Infective Agents; beta-Lactamases; Ciprofloxacin; Colony Count, Microbial; Disease Mod | 2002 |
A case of malignant external otitis involving Klebsiella oxytoca.
Topics: Aged; Aged, 80 and over; Ciprofloxacin; Drug Administration Schedule; Humans; Klebsiella; Klebsiella | 1992 |
Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
Topics: Animals; Bacteremia; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Drug Administration Schedul | 1991 |
Ciprofloxacin in neonates and its possible adverse effect on the teeth.
Topics: Ciprofloxacin; Follow-Up Studies; Humans; Infant, Newborn; Klebsiella Infections; Klebsiella pneumon | 1991 |
Quinolone therapy of Klebsiella pneumoniae sepsis following irradiation: comparison of pefloxacin, ciprofloxacin, and ofloxacin.
Topics: Animals; Ciprofloxacin; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Ofloxacin; Peflo | 1990 |
Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Ciprofloxacin; Drug Administration Schedule; Female; Ge | 1989 |
Ciprofloxacin-induced interstitial nephritis.
Topics: Adult; Ciprofloxacin; Drug Hypersensitivity; Female; Humans; Klebsiella Infections; Klebsiella pneum | 1989 |
Ciprofloxacin for cholangitis after hepatic portoenterostomy.
Topics: Biliary Atresia; Cholangitis; Ciprofloxacin; Escherichia coli Infections; Female; Humans; Infant; Kl | 1987 |
Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Ciprofloxacin; Escherichia coli; Escherichia coli Infections; Female; Human | 1985 |
Chemotherapeutic effects of ofloxacin (HOE 280) and other quinolone-carboxylic derivates in the treatment of experimental lung infections due to Klebsiella pneumoniae DT-S in mice.
Topics: Animals; Anti-Bacterial Agents; Ciprofloxacin; Dose-Response Relationship, Drug; Enoxacin; Klebsiell | 1986 |
Activity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.
Topics: Animals; Anti-Infective Agents; Anti-Infective Agents, Urinary; Bacteria; Chemical Phenomena; Chemis | 1988 |
Therapeutic effect of fleroxacin against experimental pneumonia in mice.
Topics: Animals; Anti-Infective Agents; Cefaclor; Ciprofloxacin; Fleroxacin; Klebsiella Infections; Klebsiel | 1988 |
Comparative efficacy of ciprofloxacin, ceftazidime and gentamicin, given alone or in combination, in a model of experimental septicemia due to Klebsiella pneumoniae in neutropenic mice.
Topics: Agranulocytosis; Animals; Ceftazidime; Ciprofloxacin; Disease Models, Animal; Drug Therapy, Combinat | 1988 |
Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats.
Topics: Animals; Ceftazidime; Ciprofloxacin; Drug Administration Schedule; Female; Klebsiella Infections; Kl | 1987 |
Influence of dose frequency on the therapeutic efficacies of ciprofloxacin and ceftazidime in experimental Klebsiella pneumoniae pneumonia and septicemia in relation to their bactericidal activities in vitro.
Topics: Animals; Ceftazidime; Ciprofloxacin; Drug Administration Schedule; Klebsiella Infections; Klebsiella | 1987 |
In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Ciprofloxacin; Enterobacteriaceae In | 1986 |